Microvascular Endothelial Dysfunction Can Predict Dementia

This article originally appeared here.
Share this content:
Microvascular Endothelial Dysfunction Can Predict Dementia
Microvascular Endothelial Dysfunction Can Predict Dementia

FRIDAY, April 21, 2017 (HealthDay News) -- Markers of microvascular endothelial dysfunction can predict dementia, according to a study published online April 13 in the Journal of Internal Medicine.

Hilma Holm, from Lund University in Malmö, Sweden, and colleagues examined the longitudinal association of midregional pro-atrial natriuretic peptide (MR-proANP), C-terminal endothelin-1 (CT-proET-1), and midregional pro-adrenomedullin (MR-proADM) with dementia in a population-based cohort of 5,347 individuals without prevalent dementia (age, 69 ± 6 years).

Over a period of 4.6 ± 1.3 years, 373 patients were diagnosed with dementia. The researchers found that there were significant associations for higher levels of MR-proANP with increased risk of all-cause and vascular dementia (hazard ratio per one standard deviation, 1.2 and 1.52, respectively). Across quartiles of MR-proANP, there was an increase in the risk of all-cause dementia (hazard ratio, 1.83 for quartile 4 versus 1), which was most pronounced for vascular type (hazard ratio, 2.71). Vascular dementia was predicted by the two highest quartiles of CT-proET-1, with a cut-off value at 68 pmol/L (hazard ratio, 1.94 for quartiles 3 to 4 versus 1 to 2). After adjustment for traditional risk factors, elevated levels of MR-proADM indicated no increased risk of developing dementia.

"Elevated plasma concentration of MR-proANP is an independent predictor of all-cause and vascular dementia," the authors write. "Pronounced increase in CT-proET-1 indicates higher risk of vascular dementia."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves First Generic EpiPen

FDA Approves First Generic EpiPen

Approval will address both rising costs and shortages of epinephrine

Report Details Corneal Infection Tied to Sleeping in Contacts

Report Details Corneal Infection Tied to Sleeping in ...

Six patients reported sleeping in lenses on regular basis; most had vision loss, permanent damage

Honey May Protect Children Who Swallow Button Batteries

Honey May Protect Children Who Swallow Button Batteries

Honey and Carafate appear to rapidly protect against batteries' caustic effects

is free, fast, and customized just for you!




Already a member?

Sign In Now »